These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24366746)
1. Dihydroquinazolinone inhibitors of proliferation of blood and liver stage malaria parasites. Derbyshire ER; Min J; Guiguemde WA; Clark JA; Connelly MC; Magalhães AD; Guy RK; Clardy J Antimicrob Agents Chemother; 2014; 58(3):1516-22. PubMed ID: 24366746 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794 [TBL] [Abstract][Full Text] [Related]
3. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum. Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941 [TBL] [Abstract][Full Text] [Related]
4. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211 [TBL] [Abstract][Full Text] [Related]
5. Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Derbyshire ER; Prudêncio M; Mota MM; Clardy J Proc Natl Acad Sci U S A; 2012 May; 109(22):8511-6. PubMed ID: 22586124 [TBL] [Abstract][Full Text] [Related]
6. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101 [TBL] [Abstract][Full Text] [Related]
7. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids. Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585 [TBL] [Abstract][Full Text] [Related]
8. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites. Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532 [TBL] [Abstract][Full Text] [Related]
10. 2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes. Carballeira NM; Bwalya AG; Itoe MA; Andricopulo AD; Cordero-Maldonado ML; Kaiser M; Mota MM; Crawford AD; Guido RV; Tasdemir D Bioorg Med Chem Lett; 2014 Sep; 24(17):4151-7. PubMed ID: 25103602 [TBL] [Abstract][Full Text] [Related]
12. Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites. Carrasco MP; Machado M; Gonçalves L; Sharma M; Gut J; Lukens AK; Wirth DF; André V; Duarte MT; Guedes RC; Dos Santos DJ; Rosenthal PJ; Mazitschek R; Prudêncio M; Moreira R ChemMedChem; 2016 Oct; 11(19):2194-2204. PubMed ID: 27538856 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Dual-Stage Malaria Inhibitors with New Targets. Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931 [TBL] [Abstract][Full Text] [Related]
15. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117 [TBL] [Abstract][Full Text] [Related]
16. Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability. Capela R; Magalhães J; Miranda D; Machado M; Sanches-Vaz M; Albuquerque IS; Sharma M; Gut J; Rosenthal PJ; Frade R; Perry MJ; Moreira R; Prudêncio M; Lopes F Eur J Med Chem; 2018 Apr; 149():69-78. PubMed ID: 29499488 [TBL] [Abstract][Full Text] [Related]
17. Targeting liver stage malaria with metformin. Vera IM; Grilo Ruivo MT; Lemos Rocha LF; Marques S; Bhatia SN; Mota MM; Mancio-Silva L JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852843 [TBL] [Abstract][Full Text] [Related]
18. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections. Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523 [TBL] [Abstract][Full Text] [Related]
19. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA). Satish PVV; Sunita K BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216 [TBL] [Abstract][Full Text] [Related]